INTERREG 2 Seas – IMODE – Innovative MulticOmponent Drug dEsign (Advanced materials and pharmaceutical technologies)
Goals:
- Reinforce R&D by designing innovative drugs and medical devices, ready to use and patentable, based on new multi-component materials with enhanced therapeutic properties
- Ensure the knowledge transfer to provide a high-qualified labor force (scientists and technicians from both academic and industrial community, students)
Activities carried out by Eurasanté:
- Technological transfer
- Communication activities, building a network and organizing events
- Provide a support in medical, marketing, training and networking fields
Duration: 48 months
Official start: from 01/07/2016 to 30/06/2021
Budget: € 5 910 275
Head of project: University of Lille – Sciences and Technologies – FR
- Eurasanté (FR)
- University of Lille – Faculty of medicine (FR)
- ImaBiotech (FR)
- Roquette Frères (FR)
- University College of London (UK)
- University of East Anglia (UK)
- University of Greenwich (UK)
- Ashford and St. Peter’s Hospitals NHS Foundation Trust (UK)
- Cubic Pharmaceutical Ltd (UK)
- University of Ghent (BE)
With the support of the European Regional Development Fund
